Home / Brands / Sato Pharmaceutical
Sato Pharmaceutical Recalls
10 recalls on record · May 31, 2017 to June 10, 2026 · Drugs, Food & Beverage
Recalls by year
17
19
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
June 10, 2026Food & BeverageFDA
Sato Pharmaceutical Inc. recalls Yunker(branded) Energy & Health Herbal Supplement with Vitamins; Manufactured by Sato Pharmaceuticals Co. Ltd.; 30ml con
Hazard: Product does not meet label claim for Vitamin E.
February 4, 2026DrugsFDA
Sato Pharmaceutical Co., Ltd recalls INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured
Hazard: Failed Disintegration Specifications: above the time expected.
November 20, 2019DrugsFDA
Sato Pharmaceutical Inc. recalls Motion Sickness Strips (meclizine hydrochloride) 25 mg strips, 8-count box, Distributed by Sato Pharmaceutical INC. 2069
Hazard: Subpotent Drug
November 20, 2019DrugsFDA
Sato Pharmaceutical Inc. recalls WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3 11917-18328 2 ) and
Hazard: Subpotent Drug
November 20, 2019DrugsFDA
Sato Pharmaceutical Inc. recalls Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. 20695 S.
Hazard: Subpotent Drug
November 20, 2019DrugsFDA
Sato Pharmaceutical Inc. recalls Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box, Distributed by Sato Pharmaceutical INC. 20695 S. West
Hazard: Subpotent Drug
November 13, 2019DrugsFDA
Sato Pharmaceutical Inc. recalls Sankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36 mg) tablets, 150-count bottles, Manufactured by
Hazard: Subpotent Drug: Formulated amount of sennosides component is less than labelled claim.
May 31, 2017DrugsFDA
Sato Pharmaceutical Inc. recalls DORAMA-NEO (naphazoline hydrochloride) Eye wash, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceutic
Hazard: Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.
May 31, 2017DrugsFDA
Sato Pharmaceutical Inc. recalls SATO CLEAR (naphazoline hydrochloride) Redness Reliever Eye Drops, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by
Hazard: Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.
May 31, 2017DrugsFDA
Sato Pharmaceutical Inc. recalls Optic Splash (naphazoline hydrochloride) Eye Drops, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceu
Hazard: Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.